10-Year-Results of the prospective German-Austrian Phase II Multicenter study for risk-adapted Radiotherapy of localized Prostate Cancer with a moderate Dose Escalation from 70 to 74 Gy

被引：0
|
作者：
Goldner, G. [1 ]
Bombosch, V. [2 ]
Becker, G. [3 ]
Wachter, S. [4 ]
Glocker, S. [5 ]
Feldmann, H. [6 ]
Bamberg, M. [5 ]
Poetter, R. [2 ]
Molls, M. [7 ]
Geinitz, H. [8 ]
机构：
[1] Med Univ Wien, Klin Strahlentherapie & Biol, Vienna, Austria
[2] Med Univ Wien, Vienna, Austria
[3] Klin Eichert, Goppingen, Germany
[4] Klinikum Passau, Passau, Germany
[5] Univ Klinikum Tubingen, Tubingen, Germany
[6] Stadtklinikum, Fulda, Germany
[7] Tech Univ Munich, Klinikum Rechts Isar, D-80290 Munich, Germany
[8] Krankenhaus Barmherzigen Schwestern, Linz, Austria
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2014年 / 190卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：37 / 38
页数：2
相关论文
共 25 条
  • [21] Patient-reported Outcomes After External Beam Radiotherapy With Low Dose Rate Brachytherapy Boost vs Radical Prostatectomy for Localized Prostate Cancer: Five-year Results From a Prospective Comparative Effectiveness Study
    De, Brian
    Pasalic, Dario
    Barocas, Daniel A.
    Wallis, Christopher J. D.
    Huang, Li-Ching
    Zhao, Zhiguo
    Koyama, Tatsuki
    Tang, Chad
    Goodman, Michael
    Hamilton, Ann S.
    Wu, Xiao-Cheng
    Paddock, Lisa E.
    Stroup, Antoinette
    Cooperberg, Matthew R.
    Hashibe, Mia
    O'Neil, Brock B.
    Kaplan, Sherrie H.
    Greenfield, Sheldon
    Penson, David F.
    Hoffman, Karen E.
    JOURNAL OF UROLOGY, 2022, 208 (06): : 1226 - 1239
  • [22] Stereotactic body radiotherapy (SBRT) versus conventional fractionated intensity-modulated radiotherapy (CF-IMRT) for Asian patients with early-stage localized prostate cancer: Acute toxicity results from a prospective randomized phase II study
    Poon, D. M.
    Lam, D.
    Wong, K.
    Mok, F.
    Mo, F.
    Chu, C. M.
    Ng, A. C. F.
    Suen, J.
    Chan, A. T. C.
    ANNALS OF ONCOLOGY, 2018, 29
  • [23] Patient-reported Outcomes After External Beam Radiotherapy With Low Dose Rate Brachytherapy Boost vs Radical Prostatectomy for Localized Prostate Cancer: Five-year Results From a Prospective Comparative Effectiveness Study Reply by Authors
    不详
    JOURNAL OF UROLOGY, 2022, 208 (06): : 1239 - 1239
  • [24] Reply to Leonard P. Bokhorst and Berdine L. Heesterman's Words of Wisdom re: High-dose Radiotherapy and Risk-adapted Androgen Deprivation in Localised Prostate Cancer (DART 01/05): 10-Year Results of a Phase 3Randomised, Controlled Trial. Eur Urol. 2022;82:441
    Zapatero, Almudena
    Calvo, Felipe A.
    San-Segundo, Carmen Gonzalez
    Alvarez, Ana
    EUROPEAN UROLOGY, 2022, 82 (06) : E177 - E178
  • [25] Patient-reported Outcomes After External Beam Radiotherapy With Low Dose Rate Brachytherapy Boost vs Radical Prostatectomy for Localized Prostate Cancer: Five-year Results From a Prospective Comparative Effectiveness Study (vol 208, pg 1226, 2022)
    De, Brian
    Pasalic, Dario
    Barocas, Daniel A.
    Wallis, Christopher J. D.
    Huang, Li-Ching
    Zhao, Zhiguo
    Koyama, Tatsuki
    Tang, Chad
    Goodman, Michael
    Hamilton, Ann S.
    Wu, Xiao-Cheng
    Paddock, Lisa E.
    Stroup, Antoinette
    Cooperberg, Matthew R.
    Hashibe, Mia
    O'Neil, Brock B.
    Kaplan, Sherrie H.
    Greenfield, Sheldon
    Penson, David F.
    Hoffman, Karen E.
    JOURNAL OF UROLOGY, 2023, 209 (02): : 450 - 450
123